As the clock ticks down on 2024, Novo Holdings’ proposed $16.5 billion buyout of CDMO giant Catalent—which the companies have ...
Amid ongoing speculation about how the biopharmaceutical sector will fare under Donald Trump's second presidency, the ...
Despite expanding and adding hundreds of new jobs in states like Ohio in the past year, biomanufacturing CDMO National ...
Sanofi unveiled a plan to build a $1 billion manufacturing site in Beijing while completing construction at a plant in ...
That’s according to the latest data from real-time ad trackers iSpot.TV. Their analysts found AbbVie’s immunology drug duo ...
Novo will drop its U.S. list price for its Fiasp by 75% and for Tresiba by 72%, the Danish company said in a release. The new ...
ViiV Healthcare wants people to go deep when talking about HIV rather than merely skimming the surface of the experience of ...
LinkedIn likes have landed drugmakers in trouble once again. AstraZeneca—a repeat offender—and GSK were the subjects of the ...
Taiwan-headquartered PharmaEssentia has tapped Joseph Horvat as its new global chief commercial officer as it looks to boost ...
These days, with its revenue booming and a market cap swelling to twice the size of | Eli Lilly said it will spend $3 billion ...
Teva has reached an agreement to sell Teva Takeda Pharma to JKI, which was established by private equity firm J-Will Partners, the Israeli pharma company said Thursday. To make the deal happen, Takeda ...
Amid a flurry of manufacturing activity in the state this year, Amgen is the latest drugmaker to bolster its production ...